Viviane Timmermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Viviane Timmermann has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Albert Dasí
Department of Computer Science University of Oxford Oxford UK
2 shared publications- Franziska Schneider-Warme
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg – Bad Krozingen, Medical Faculty and Medical Center – University of Freiburg, Freiburg im Breisgau, Germany
2 shared publications - Joachim Greiner
Institute for Experimental Cardiovascular Medicine, University Heart Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany
2 shared publications - Johannes Vierock
Charité – Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Neurocure Cluster of Excellence Berlin Germany
2 shared publications Linda Tillert
Charité – Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Neurocure Cluster of Excellence Berlin Germany
2 shared publications- Patrick M. Boyle
Department of Bioengineering University of Washington Seattle Washington USA
2 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Wiley in The Journal of Physiology
Channelrhodopsin ion selectivity determines mechanisms and efficacy of optogenetic defibrillation in human atria and ventricles
Cardiac re‐entrant arrhythmias are a major cause of sudden cardiac death. Optogenetic defibrillation has emerged as a promising anti‐arrhythmic strategy based on photoactivation of channelrhodopsins, yet the efficacy and potential adverse consequences of activating different classes of light‐gated ion channels have not been systematically evaluated. Previous studies assessed either cation (e.g. ChR2) or anion (e.g. GtACR1) non‐selective channels, both of which depolarize resting cardiomyocytes. Recently identified light‐gated K + channels (e.g. WiChR) suppress cardiomyocyte activity while maintaining the membrane potential near its resting state, but their defibrillation potential remains unexplored. We used computational simulations to compare ChR2, GtACR1 and WiChR. Single‐cell simulations showed that ChR2 and GtACR1 markedly increased diastolic intracellular Ca 2+ (by 42.6% and 52.6%, respectively), whereas WiChR induced only minimal changes (by 4.0%), suggesting lower pro‐arrhythmogenic risk. WiChR, however, slightly increased intracellular Na + (by 15.1% vs . 0.1% and 3.4% for ChR2 and GtACR1), consistent with the residual Na + permeability of currently available K + ‐conducting channelrhodopsins. Simulations in human ventricles and atria showed that GtACR1 most effectively terminated re‐entrant arrhythmias at low light intensities, whereas WiChR achieved comparable efficacy at ≥5 mW/mm 2 . Complementary tissue‐scale simulations revealed that defibrillation occurs through depolarization within the excitable gap followed by fast Na + channel inactivation (ChR2 and partly GtACR1), or through reduced membrane resistance at sufficiently high light intensities (large‐conductance channels GtACR1 and WiChR). Overall, we demonstrate that channelrhodopsin ion selectivity is a key determinant of both optogenetic defibrillation efficacy and its underlying mechanisms. image Translational perspective: Re‐entrant arrhythmias are a leading cause of sudden cardiac death. Standard therapies, including the activation of implantable cardioverter‐defibrillators, carry burdens such as pain and myocardial injury. Optogenetic defibrillation has been suggested as a potentially gentler alternative, replacing high‐voltage electrical shocks by photoactivation of light‐gated ion channels expressed in cardiac cells. Determining which light‐gated ion channel optimally balances efficacy and adverse effects on cardiac electrophysiology is critical for clinical translation. We addressed this question using computational simulations and validation experiments in zebrafish hearts. We identify ion selectivity as a key determinant of both the success rate for arrhythmia termination and the underlying mechanisms: non‐selective cation‐ and anion‐conducting channels terminate re‐entry efficiently while promoting intracellular Ca 2+ accumulation, a plausible substrate for pro‐arrhythmic side effects that could undermine therapeutic safety. K + ‐conducting channels largely avoid this pro‐arrhythmic risk by holding cardiomyocytes near their resting potential, albeit at the cost of requiring transmural illumination, while also causing mild Na + accumulation attributable to residual Na + permeability. Together, these trade‐offs define clear clinical implications: K + ‐conducting channels may provide the safest option for optogenetic defibrillation, particularly once variants with further enhanced K + selectivity and red‐shifted activation spectra for improved operation within blood‐perfused myocardium become available. Key points: We use computational simulations to compare cation non‐selective (ChR2), anion non‐selective (GtACR1) and K + ‐selective (WiChR) channelrhodopsins for optogenetic termination of re‐entrant arrhythmia. Single‐cardiomyocyte simulations suggest that ChR2 and GtACR1 activation can cause progressive accumulation of intracellular Ca 2+ , which is minimized when using WiChR. Intracellular microelectrode recordings from hearts of transgenic adult zebrafish validate the simulated voltage dynamics seen with ChR2, GtACR1 or WiChR activation. Simulations of human left ventricles and atria indicate that GtACR1 is most effective in terminating re‐entrant arrhythmia at low light intensities, whereas WiChR becomes similarly effective at higher intensities. Tissue‐scale simulations indicate distinct defibrillation mechanisms: excitable gap extinction by de novo action potential initiation followed by inactivation of fast Na + channels for depolarizing channelrhodopsins (ChR2, GtACR1), and reduction in membrane resistance for the large‐conductance channels (GtACR1, WiChR), effectively clamping the membrane potential at each channel's reversal potential at high light levels.
- 17 October 2026
- Published by Wiley in The Journal of Physiology
Open AccessChannelrhodopsin ion selectivity determines mechanisms and efficacy of optogenetic defibrillation in human atria and ventricles
Cardiac re‐entrant arrhythmias are a major cause of sudden cardiac death. Optogenetic defibrillation has emerged as a promising anti‐arrhythmic strategy based on photoactivation of channelrhodopsins, yet the efficacy and potential adverse consequences of activating different classes of light‐gated ion channels have not been systematically evaluated. Previous studies assessed either cation (e.g. ChR2) or anion (e.g. GtACR1) non‐selective channels, both of which depolarize resting cardiomyocytes. Recently identified light‐gated K + channels (e.g. WiChR) suppress cardiomyocyte activity while maintaining the membrane potential near its resting state, but their defibrillation potential remains unexplored. We used computational simulations to compare ChR2, GtACR1 and WiChR. Single‐cell simulations showed that ChR2 and GtACR1 markedly increased diastolic intracellular Ca 2+ (by 42.6% and 52.6%, respectively), whereas WiChR induced only minimal changes (by 4.0%), suggesting lower pro‐arrhythmogenic risk. WiChR, however, slightly increased intracellular Na + (by 15.1% vs . 0.1% and 3.4% for ChR2 and GtACR1), consistent with the residual Na + permeability of currently available K + ‐conducting channelrhodopsins. Simulations in human ventricles and atria showed that GtACR1 most effectively terminated re‐entrant arrhythmias at low light intensities, whereas WiChR achieved comparable efficacy at ≥5 mW/mm 2 . Complementary tissue‐scale simulations revealed that defibrillation occurs through depolarization within the excitable gap followed by fast Na + channel inactivation (ChR2 and partly GtACR1), or through reduced membrane resistance at sufficiently high light intensities (large‐conductance channels GtACR1 and WiChR). Overall, we demonstrate that channelrhodopsin ion selectivity is a key determinant of both optogenetic defibrillation efficacy and its underlying mechanisms. image Translational perspective: Re‐entrant arrhythmias are a leading cause of sudden cardiac death. Standard therapies, including the activation of implantable cardioverter‐defibrillators, carry burdens such as pain and myocardial injury. Optogenetic defibrillation has been suggested as a potentially gentler alternative, replacing high‐voltage electrical shocks by photoactivation of light‐gated ion channels expressed in cardiac cells. Determining which light‐gated ion channel optimally balances efficacy and adverse effects on cardiac electrophysiology is critical for clinical translation. We addressed this question using computational simulations and validation experiments in zebrafish hearts. We identify ion selectivity as a key determinant of both the success rate for arrhythmia termination and the underlying mechanisms: non‐selective cation‐ and anion‐conducting channels terminate re‐entry efficiently while promoting intracellular Ca 2+ accumulation, a plausible substrate for pro‐arrhythmic side effects that could undermine therapeutic safety. K + ‐conducting channels largely avoid this pro‐arrhythmic risk by holding cardiomyocytes near their resting potential, albeit at the cost of requiring transmural illumination, while also causing mild Na + accumulation attributable to residual Na + permeability. Together, these trade‐offs define clear clinical implications: K + ‐conducting channels may provide the safest option for optogenetic defibrillation, particularly once variants with further enhanced K + selectivity and red‐shifted activation spectra for improved operation within blood‐perfused myocardium become available. Key points: We use computational simulations to compare cation non‐selective (ChR2), anion non‐selective (GtACR1) and K + ‐selective (WiChR) channelrhodopsins for optogenetic termination of re‐entrant arrhythmia. Single‐cardiomyocyte simulations suggest that ChR2 and GtACR1 activation can cause progressive accumulation of intracellular Ca 2+ , which is minimized when using WiChR. Intracellular microelectrode recordings from hearts of transgenic adult zebrafish validate the simulated voltage dynamics seen with ChR2, GtACR1 or WiChR activation. Simulations of human left ventricles and atria indicate that GtACR1 is most effective in terminating re‐entrant arrhythmia at low light intensities, whereas WiChR becomes similarly effective at higher intensities. Tissue‐scale simulations indicate distinct defibrillation mechanisms: excitable gap extinction by de novo action potential initiation followed by inactivation of fast Na + channels for depolarizing channelrhodopsins (ChR2, GtACR1), and reduction in membrane resistance for the large‐conductance channels (GtACR1, WiChR), effectively clamping the membrane potential at each channel's reversal potential at high light levels.
- Open Access
An ER Retrieval-and-Release System Reveals Ligand-Independent Basal Signaling by Cell Surface TCRs
The T cell receptor (TCR) machinery comprises the ligand-binding TCRαβ and the CD3 signaling dimers. Individual subunits are synthesized in the endoplasmic reticulum (ER) and only the fully assembled TCRs reach the cell surface. We engineered a system to retained CD3ε is in the ER. This allowed only partial TCR assembly, while continuous retrieval of CD3ε from the Golgi back to the ER enabled complete assembly. Synchronous TCR release by biotin addition caused a transient increase in surface TCR abundance that gradually returned to steady-state levels. Mathematical modeling revealed that TCR levels were controlled by feedback mechanisms. Notably, surface-localized, but not ER-localized, TCRs spontaneously generated ligand-independent basal signaling. Phosphoproteomic analyses revealed that this signal is similar, but not identical, to ligand-induced TCR activation signals, with distinct phosphorylation patterns already evident at the CD3 subunits. Our findings establish the TCR retrieval-and-release system as a tool to investigate ligand-independent basal TCR signaling.
Open AccessAn ER Retrieval-and-Release System Reveals Ligand-Independent Basal Signaling by Cell Surface TCRs
The T cell receptor (TCR) machinery comprises the ligand-binding TCRαβ and the CD3 signaling dimers. Individual subunits are synthesized in the endoplasmic reticulum (ER) and only the fully assembled TCRs reach the cell surface. We engineered a system to retained CD3ε is in the ER. This allowed only partial TCR assembly, while continuous retrieval of CD3ε from the Golgi back to the ER enabled complete assembly. Synchronous TCR release by biotin addition caused a transient increase in surface TCR abundance that gradually returned to steady-state levels. Mathematical modeling revealed that TCR levels were controlled by feedback mechanisms. Notably, surface-localized, but not ER-localized, TCRs spontaneously generated ligand-independent basal signaling. Phosphoproteomic analyses revealed that this signal is similar, but not identical, to ligand-induced TCR activation signals, with distinct phosphorylation patterns already evident at the CD3 subunits. Our findings establish the TCR retrieval-and-release system as a tool to investigate ligand-independent basal TCR signaling.
- Open Access
Human NHE1 binds full-length calcineurin with high affinity and inhibits substrate dephosphorylation
Calcineurin (Cn) interacts with the Na+/H+-exchanger NHE1 through its calcineurin-binding domain (NHE1-CnBD). How activation of full-length Cn influences this interaction and its functional consequences has remained unclear. Here, we quantified the interaction between full-length human Cn and NHE1-CnBD in distinct activation states using fluorescence anisotropy and quantitative size-exclusion chromatography. Ca2+/calmodulin activation increased Cn affinity for NHE1-CnBD from submicromolar to tens of nanomolar affinity and stabilized the complex. NHE1-CnBD outcompeted the immunosuppressive cyclosporin A/cyclophilin A complex for Cn binding and selectively inhibited dephosphorylation of a phosphopeptide substrate while enhancing hydrolysis of p-nitrophenyl phosphate. These findings identify NHE1 as a high-affinity, substrate-competitive Cn regulator that blocks substrate recognition rather than catalysis, providing a mechanistic framework for reciprocal regulation between Cn and NHE1.
Open AccessHuman NHE1 binds full-length calcineurin with high affinity and inhibits substrate dephosphorylation
Calcineurin (Cn) interacts with the Na+/H+-exchanger NHE1 through its calcineurin-binding domain (NHE1-CnBD). How activation of full-length Cn influences this interaction and its functional consequences has remained unclear. Here, we quantified the interaction between full-length human Cn and NHE1-CnBD in distinct activation states using fluorescence anisotropy and quantitative size-exclusion chromatography. Ca2+/calmodulin activation increased Cn affinity for NHE1-CnBD from submicromolar to tens of nanomolar affinity and stabilized the complex. NHE1-CnBD outcompeted the immunosuppressive cyclosporin A/cyclophilin A complex for Cn binding and selectively inhibited dephosphorylation of a phosphopeptide substrate while enhancing hydrolysis of p-nitrophenyl phosphate. These findings identify NHE1 as a high-affinity, substrate-competitive Cn regulator that blocks substrate recognition rather than catalysis, providing a mechanistic framework for reciprocal regulation between Cn and NHE1.
- Open Access
Channelrhodopsin Ion Selectivity Determines Mechanisms and Efficacy of Optogenetic Defibrillation in Human Atria and Ventricles
Optogenetic defibrillation uses light-gated ion channels to terminate cardiac arrhythmias through targeted illumination. Previous studies assessed the feasibility of using either cation (e.g. ChR2) or anion (e.g. GtACR1) non-selective channels, both of which depolarise resting cardiomyocytes upon photoactivation. In contrast, recently identified light-gated K + -channels (e.g. WiChR) suppress cardiomyocyte activity while maintaining the membrane potential near its resting state. Here, we use biophysically detailed simulations to compare the defibrillation potential of ChR2, GtACR1, and WiChR. Single-cell simulations show that activation of ChR2 and GtACR1 markedly increase diastolic intracellular Ca 2+ concentration (by 42.6% and 52.6%, respectively), whereas WiChR induces only minimal changes (4.0% increase), suggesting a lower pro-arrhythmogenic risk. WiChR activation, however, slightly increases intracellular Na + levels (by 15.1% compared to 0.1% and 3.4% for ChR2 and GtACR), consistent with the residual Na + permeability of all currently available K + -selective channelrhodopsins. Simulations of human ventricles and atria demonstrate that GtACR1 most effectively terminates re-entrant arrhythmias at low light intensities, while WiChR achieves comparable efficacy at light levels ≥5 mW/mm 2 . Complementary tissue-scale simulations reveal that defibrillation is either based on depolarisation within the excitable gap, followed by fast Na + channel inactivation (depolarising variants ChR2 and GtACR1), or based on a reduction in membrane resistance supporting arrhythmia termination at sufficiently high light levels (large-conductance ion channels GtACR1 and WiChR). Overall, our findings identify channelrhodopsin ion selectivity as a key determinant of both arrhythmia termination success and mechanisms underlying defibrillation. Key points summary: We use computational simulations to compare non-selective cation (ChR2), anion (GtACR1), and K + -selective channelrhodopsins (WiChR) for optogenetic termination of re-entrant arrhythmia. Single-cardiomyocyte simulations suggest that ChR2 and GtACR1 activation can cause progressive accumulation of intracellular Ca 2+ , which is minimised when using WiChR. Simulations of human left ventricles and atria indicate that GtACR1 is most effective in terminating re-entrant arrhythmia at low light intensities, while WiChR becomes similarly effective at higher intensities. Tissue-scale simulations indicate distinct defibrillation mechanisms: Excitable gap extinction by de-novo action potential initiation followed by inactivation of fast Na + channels for depolarising channelrhodopsins (ChR2, GtACR1), and reduction in membrane resistance for the large-conductance channels (GtACR1, WiChR), effectively clamping the membrane potential at each channel’s reversal potential at high light levels.
Open AccessChannelrhodopsin Ion Selectivity Determines Mechanisms and Efficacy of Optogenetic Defibrillation in Human Atria and Ventricles
Optogenetic defibrillation uses light-gated ion channels to terminate cardiac arrhythmias through targeted illumination. Previous studies assessed the feasibility of using either cation (e.g. ChR2) or anion (e.g. GtACR1) non-selective channels, both of which depolarise resting cardiomyocytes upon photoactivation. In contrast, recently identified light-gated K + -channels (e.g. WiChR) suppress cardiomyocyte activity while maintaining the membrane potential near its resting state. Here, we use biophysically detailed simulations to compare the defibrillation potential of ChR2, GtACR1, and WiChR. Single-cell simulations show that activation of ChR2 and GtACR1 markedly increase diastolic intracellular Ca 2+ concentration (by 42.6% and 52.6%, respectively), whereas WiChR induces only minimal changes (4.0% increase), suggesting a lower pro-arrhythmogenic risk. WiChR activation, however, slightly increases intracellular Na + levels (by 15.1% compared to 0.1% and 3.4% for ChR2 and GtACR), consistent with the residual Na + permeability of all currently available K + -selective channelrhodopsins. Simulations of human ventricles and atria demonstrate that GtACR1 most effectively terminates re-entrant arrhythmias at low light intensities, while WiChR achieves comparable efficacy at light levels ≥5 mW/mm 2 . Complementary tissue-scale simulations reveal that defibrillation is either based on depolarisation within the excitable gap, followed by fast Na + channel inactivation (depolarising variants ChR2 and GtACR1), or based on a reduction in membrane resistance supporting arrhythmia termination at sufficiently high light levels (large-conductance ion channels GtACR1 and WiChR). Overall, our findings identify channelrhodopsin ion selectivity as a key determinant of both arrhythmia termination success and mechanisms underlying defibrillation. Key points summary: We use computational simulations to compare non-selective cation (ChR2), anion (GtACR1), and K + -selective channelrhodopsins (WiChR) for optogenetic termination of re-entrant arrhythmia. Single-cardiomyocyte simulations suggest that ChR2 and GtACR1 activation can cause progressive accumulation of intracellular Ca 2+ , which is minimised when using WiChR. Simulations of human left ventricles and atria indicate that GtACR1 is most effective in terminating re-entrant arrhythmia at low light intensities, while WiChR becomes similarly effective at higher intensities. Tissue-scale simulations indicate distinct defibrillation mechanisms: Excitable gap extinction by de-novo action potential initiation followed by inactivation of fast Na + channels for depolarising channelrhodopsins (ChR2, GtACR1), and reduction in membrane resistance for the large-conductance channels (GtACR1, WiChR), effectively clamping the membrane potential at each channel’s reversal potential at high light levels.
- Open Access
An In-Silico Study on Integrated Mechanisms of Mechano-Electric Coupling in Ischaemic Arrhythmogenesis
Heterogeneous mechanical dyskinesis during acute myocardial ischaemia is thought to contribute to arrhythmogenic alterations to cardiac electrophysiology. Various forms of mechano-electric coupling (MEC) mechanisms have been suggested to contribute to these changes, with two primary mechanisms being: (1) myofilament-dependent calcium release events, and (2) the activation of stretch-activated currents (SACs). In this computational investigation, we assessed the collective impact of these processes on mechanically-induced alternans that create an arrhythmogenic substrate during acute ischaemia. To appraise the potential involvement of MEC in ischaemia-induced arrhythmias, we developed a coupled model of ventricular myocyte electrophysiology and contraction including SACs and stretch-dependent calcium buffering and release. The model, reflecting observed electrophysiological changes during ischaemia, was exposed to a series of stretch protocols that replicated both physiological and pathological mechanical conditions. Pathologically realistic myofiber stretch variations revealed calcium sensitivity changes dependent on myofilament, leading to alterations in cytosolic calcium concentrations. Under calcium overload conditions, these changes resulted in electrical alternans. The study implies that strain impacts cellular electrophysiology through myofilament calcium release and SAC opening in ventricular mechano-electrical models, parameterised to available data. This supports experimental evidence suggesting that both calcium-driven instability via MEC and SAC-induced effects contribute to electrical alternans in acute ischaemia.
Open AccessAn In-Silico Study on Integrated Mechanisms of Mechano-Electric Coupling in Ischaemic Arrhythmogenesis
Heterogeneous mechanical dyskinesis during acute myocardial ischaemia is thought to contribute to arrhythmogenic alterations to cardiac electrophysiology. Various forms of mechano-electric coupling (MEC) mechanisms have been suggested to contribute to these changes, with two primary mechanisms being: (1) myofilament-dependent calcium release events, and (2) the activation of stretch-activated currents (SACs). In this computational investigation, we assessed the collective impact of these processes on mechanically-induced alternans that create an arrhythmogenic substrate during acute ischaemia. To appraise the potential involvement of MEC in ischaemia-induced arrhythmias, we developed a coupled model of ventricular myocyte electrophysiology and contraction including SACs and stretch-dependent calcium buffering and release. The model, reflecting observed electrophysiological changes during ischaemia, was exposed to a series of stretch protocols that replicated both physiological and pathological mechanical conditions. Pathologically realistic myofiber stretch variations revealed calcium sensitivity changes dependent on myofilament, leading to alterations in cytosolic calcium concentrations. Under calcium overload conditions, these changes resulted in electrical alternans. The study implies that strain impacts cellular electrophysiology through myofilament calcium release and SAC opening in ventricular mechano-electrical models, parameterised to available data. This supports experimental evidence suggesting that both calcium-driven instability via MEC and SAC-induced effects contribute to electrical alternans in acute ischaemia.